Related Experiment Video
Updated: Mar 14, 2026
07:28
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
41.7K
Advanced Therapeutic Strategies for Chronic Lung Disease Using Nanoparticle-Based Drug Delivery
Ji Young Yhee1, Jintaek Im2, Richard Seonghun Nho3
1Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA. jyheephd@umn.edu.
Journal of Clinical Medicine
|September 23, 2016
Summary
Nanoparticles offer a promising advanced strategy for treating chronic lung diseases like asthma and COPD. This review explores how nanoparticle drug delivery systems enhance therapeutic effectiveness and pharmacokinetics for better patient outcomes.
Area of Science:
- Pulmonary Medicine
- Nanotechnology
- Pharmacology
Background:
- Chronic lung diseases, including asthma, COPD, cystic fibrosis, IPF, and lung cancers, pose significant health challenges.
- Effective pharmacotherapy is crucial for managing these conditions.
- Nanoparticle-based drug delivery presents a promising avenue for advanced therapeutic strategies.
Purpose of the Study:
- To review nanoparticle-based drug delivery systems for chronic lung disease treatment.
- To introduce various types of nanoparticles used in this context.
- To discuss innovative applications of nanoparticles as drug carriers.
Main Methods:
- Literature review of nanoparticle-based drug delivery systems.
- Analysis of nanoparticle biophysical properties and their impact on pharmacokinetics.
- Discussion of recent advancements and innovative efforts in the field.
Main Results:
- Nanoparticles demonstrate potential for improved pharmacokinetics and controlled drug delivery.
- Various nanoparticle types show promise for targeted and effective treatment of chronic lung diseases.
- Innovative applications highlight the versatility of nanoparticles as drug carriers.
Conclusions:
- Nanoparticle drug delivery systems represent a significant advancement in treating chronic lung diseases.
- Further research and development in this area hold great potential for improving patient outcomes.
- The review underscores the importance of exploring novel nanoparticle-based therapies for pulmonary conditions.
Related Concept Videos
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.4K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.4K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.4K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.4K
01:23Inhaled Medications
952
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
952
01:22Drug Delivery: Miscellaneous Routes
932
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
932
01:26COPD: Management Using Bronchodilators and Corticosteroids
1.0K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.0K